97328786 - X-CHEM TAKE THE LEAD. DRIVE DISCOVERY.

Information

  • Trademark
  • 97328786
  • Serial Number
    97328786
  • Registration Number
    7210307
  • Filing Date
    March 24, 2022
    2 years ago
  • Registration Date
    November 07, 2023
    7 months ago
  • Transaction Date
    November 07, 2023
    7 months ago
  • Status Date
    November 07, 2023
    7 months ago
  • Published for Opposition Date
    August 22, 2023
    10 months ago
  • Location Date
    November 07, 2023
    7 months ago
  • First Use Anywhere Date
    March 14, 2022
    2 years ago
  • First Use In Commerce Date
    March 14, 2022
    2 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    MCNAMARA, SHANA MARIE
  • Attorney Docket Number
    17711.5
    Attorney Name
    Philip J. Cardinale
    Law Office Assigned Location Code
    N70
  • Owners
Mark Drawing Code
3000
Mark Identification
X-CHEM TAKE THE LEAD. DRIVE DISCOVERY.
Case File Statements
  • GS0401: Custom production of DNA encoded compounds and libraries for others
  • DM0000: The mark consists of the stylized words X-CHEM above the stylized words TAKE THE LEAD. DRIVE DISCOVERY. Above and to the right of the letter M there are a stylized pentagon, square and hexagon.
  • GS0051: biological, chemical and biochemical preparations for the treatment of cancer, cardiovascular, gastrointestinal, musculoskeletal, infectious disease, endocrine, metabolic, central nervous system disorders, respiratory, infectious disease and blood disorders; chemico-pharmaceutical preparations for use in treatment of cancer, cardiovascular, gastrointestinal, musculoskeletal, infectious disease, endocrine, metabolic, central nervous system disorders, respiratory, infectious disease and blood disorders
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0011: Chemical, biochemical and biological substances and preparations for use in industry and science; chemical, biochemical and biological substances and preparations for use in drug research, discovery and development; DNA encoded chemical compounds for use in biochemical research and in drug research, discovery and development; DNA encoded chemical preparations for use in biochemical research and in drug research, discovery and development; DNA encoded compounds for use in industry and science; Biological, chemical, biochemical, and DNA-encoded preparations for use in science and medical research
  • GS0451: Licensing of intellectual property rights, namely, rights in compounds developed, created or included in DNA encoded compound libraries
  • GS0421: Scientific and technological research services for pharmaceutical and medical purposes; research and development services related to drug discovery; scientific research and product development services in the pharmaceutical, biotechnology and medical fields; research and development services related to screening, synthesis and analysis of DNA encoded compounds and libraries; development of DNA encoded compounds and libraries; chemical and biological research services related to drug discovery and development; chemist and chemical research services related to drug discovery and development; research and development services utilizing artificial intelligence and machine learning in the field of drug discovery; research and development involving small molecule drug discovery; providing temporary use of non-downloadable computer software, and software as a service (SAAS) services, for use in drug research, discovery and development
Case File Event Statements
  • 11/7/2023 - 7 months ago
    28 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 11/7/2023 - 7 months ago
    27 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 11/6/2023 - 7 months ago
    26 - ASSIGNED TO EXAMINER Type: DOCK
  • 8/22/2023 - 10 months ago
    25 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 8/22/2023 - 10 months ago
    24 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 8/2/2023 - 10 months ago
    23 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 7/20/2023 - 11 months ago
    22 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 7/20/2023 - 11 months ago
    21 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 7/20/2023 - 11 months ago
    20 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 7/20/2023 - 11 months ago
    19 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 7/20/2023 - 11 months ago
    18 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 6/20/2023 - a year ago
    17 - TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Type: EWAF
  • 6/20/2023 - a year ago
    16 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 6/20/2023 - a year ago
    15 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 6/20/2023 - a year ago
    14 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 4/24/2023 - a year ago
    13 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 4/24/2023 - a year ago
    12 - FINAL REFUSAL E-MAILED Type: GNFR
  • 4/24/2023 - a year ago
    11 - FINAL REFUSAL WRITTEN Type: CNFR
  • 4/20/2023 - a year ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/19/2023 - a year ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/19/2023 - a year ago
    8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 1/24/2023 - a year ago
    7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 1/24/2023 - a year ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 1/24/2023 - a year ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 1/8/2023 - a year ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/30/2022 - 2 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 3/29/2022 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 3/28/2022 - 2 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP